Search research articles
Contact Us
Filters
Showing results (271-280 of 749) with videos related to
Page
of 75
Sort By:
Haematologica
|
April 13, 2004
Second generation blood tests to detect erythropoietin abuse by athletes: effective but not preventive?
Giuseppe Lippi, Massimo Franchini, Giancesare Guidi
Thrombosis and Haemostasis
|
November 5, 2003
Deep vein thrombosis after orthopedic surgery in a patient with type 1 von Willebrand disease and mutations in the MTHFR and beta-fibrinogen genes
Massimo Franchini, Mauro Krampera, Dino Veneri
Seminars in Thrombosis and Hemostasis
|
July 2, 2016
Controversies in Inherited Bleeding Disorders
Antonio Coppola, Annarita Tagliaferri, Massimo Franchini
American Journal of Hematology
|
July 14, 2006
Treatment of hepatitis C in hemophiliacs
Massimo Franchini, Nicoletta Nicolini, Franco Capra
Thrombosis and Haemostasis
|
June 22, 2005
Recombinant factor VIIa. An update on its clinical use
Massimo Franchini, Marco Zaffanello, Dino Veneri
Annals of Clinical and Laboratory Science
|
August 22, 2007
Is serum Cystatin-C a suitable marker of renal function in children?
Marco Zaffanello, Massimo Franchini, Vassilios Fanos
The New England Journal of Medicine
|
November 15, 2008
Rivaroxaban for thromboprophylaxis
Giuseppe Lippi, Massimo Franchini, Giovanni Targher
Advances in Clinical Chemistry
|
June 5, 2010
Serum bilirubin levels and cardiovascular disease risk: a Janus Bifrons?
Massimo Franchini, Giovanni Targher, Giuseppe Lippi
Pediatric Neurology
|
June 13, 2009
Migraine, valproic acid, and lipoprotein(a)
Giuseppe Lippi, Giovanni Targher, Massimo Franchini
Seminars in Thrombosis and Hemostasis
|
April 15, 2010
The management of cardiovascular diseases in patients with hemophilia
Antonio Coppola, Annarita Tagliaferri, Massimo Franchini
Page
of 75
Search research articles
Search
Showing results (271-280 of 749) with videos related to
Sort By:
Page
of 75
Haematologica
|
April 13, 2004
Second generation blood tests to detect erythropoietin abuse by athletes: effective but not preventive?
Giuseppe Lippi, Massimo Franchini, Giancesare Guidi
Thrombosis and Haemostasis
|
November 5, 2003
Deep vein thrombosis after orthopedic surgery in a patient with type 1 von Willebrand disease and mutations in the MTHFR and beta-fibrinogen genes
Massimo Franchini, Mauro Krampera, Dino Veneri
Seminars in Thrombosis and Hemostasis
|
July 2, 2016
Controversies in Inherited Bleeding Disorders
Antonio Coppola, Annarita Tagliaferri, Massimo Franchini
American Journal of Hematology
|
July 14, 2006
Treatment of hepatitis C in hemophiliacs
Massimo Franchini, Nicoletta Nicolini, Franco Capra
Thrombosis and Haemostasis
|
June 22, 2005
Recombinant factor VIIa. An update on its clinical use
Massimo Franchini, Marco Zaffanello, Dino Veneri
Annals of Clinical and Laboratory Science
|
August 22, 2007
Is serum Cystatin-C a suitable marker of renal function in children?
Marco Zaffanello, Massimo Franchini, Vassilios Fanos
The New England Journal of Medicine
|
November 15, 2008
Rivaroxaban for thromboprophylaxis
Giuseppe Lippi, Massimo Franchini, Giovanni Targher
Advances in Clinical Chemistry
|
June 5, 2010
Serum bilirubin levels and cardiovascular disease risk: a Janus Bifrons?
Massimo Franchini, Giovanni Targher, Giuseppe Lippi
Pediatric Neurology
|
June 13, 2009
Migraine, valproic acid, and lipoprotein(a)
Giuseppe Lippi, Giovanni Targher, Massimo Franchini
Seminars in Thrombosis and Hemostasis
|
April 15, 2010
The management of cardiovascular diseases in patients with hemophilia
Antonio Coppola, Annarita Tagliaferri, Massimo Franchini
Page
of 75